Search research articles
Contact Us
Filters
Showing results (1641-1650 of 2,093) with videos related to
Page
of 210
Sort By:
Journal of Cosmetic Dermatology
|
January 13, 2016
In vitro and clinical evaluation of SIG1273: a cosmetic functional ingredient with a broad spectrum of anti-aging and antioxidant activities
José R Fernández, Karl Rouzard, Michael Voronkov, et al.
Sensors (Basel, Switzerland)
|
December 28, 2021
Assessing Plasmonic Nanoprobes in Electromagnetic Field Enhancement for SERS Detection of Biomarkers
Han-Wen Cheng, Shu-Yan Xue, Jing Li, et al.
Diagnostics (Basel, Switzerland)
|
February 10, 2021
Recurrence and Coniglobus Volumetric Resolution of Subacute and Chronic Subdural Hematoma Post-Middle Meningeal Artery Embolization
Ambooj Tiwari, Adam A Dmytriw, Ryan Bo, et al.
Pharmacoepidemiology and Drug Safety
|
August 23, 2022
Joint longitudinal trajectories of pain intensity and opioid prescription in veterans with back pain
Eugenia Buta, Kirsha S Gordon, Ralitza Gueorguieva, et al.
Addiction Science & Clinical Practice
|
April 24, 2020
Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials
Sean M Murphy, Philip J Jeng, Sabrina A Poole, et al.
The Journal of Stone Disease
|
March 9, 1992
Gallstone lithotripsy (GSL): results of the Technomed Sonolith 3000 multicenter trials
J R Adwers, S Gordon, C Abernathy, et al.
Drug and Alcohol Dependence
|
December 7, 2018
Incidence of future arrests in adults involved in the criminal justice system with opioid use disorder receiving extended release naltrexone compared to treatment as usual
William E Soares, Donna Wilson, Michael S Gordon, et al.
Investigational New Drugs
|
May 13, 2009
A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors
Anne M Traynor, Michael S Gordon, Dona Alberti, et al.
Applied Psychology. Health and Well-Being
|
October 15, 2013
A brief self-affirmation study to improve the experience of minority patients
Diana J Burgess, Brent C Taylor, Sean Phelan, et al.
Archives of Dermatological Research
|
December 19, 2016
N-Acetylglutaminoyl-S-farnesyl-L-cysteine (SIG-1191): an anti-inflammatory molecule that increases the expression of the aquaglyceroporin, aquaporin-3, in human keratinocytes
José R Fernández, Corey Webb, Karl Rouzard, et al.
Page
of 210
Search research articles
Search
Showing results (1641-1650 of 2,093) with videos related to
Sort By:
Page
of 210
Journal of Cosmetic Dermatology
|
January 13, 2016
In vitro and clinical evaluation of SIG1273: a cosmetic functional ingredient with a broad spectrum of anti-aging and antioxidant activities
José R Fernández, Karl Rouzard, Michael Voronkov, et al.
Sensors (Basel, Switzerland)
|
December 28, 2021
Assessing Plasmonic Nanoprobes in Electromagnetic Field Enhancement for SERS Detection of Biomarkers
Han-Wen Cheng, Shu-Yan Xue, Jing Li, et al.
Diagnostics (Basel, Switzerland)
|
February 10, 2021
Recurrence and Coniglobus Volumetric Resolution of Subacute and Chronic Subdural Hematoma Post-Middle Meningeal Artery Embolization
Ambooj Tiwari, Adam A Dmytriw, Ryan Bo, et al.
Pharmacoepidemiology and Drug Safety
|
August 23, 2022
Joint longitudinal trajectories of pain intensity and opioid prescription in veterans with back pain
Eugenia Buta, Kirsha S Gordon, Ralitza Gueorguieva, et al.
Addiction Science & Clinical Practice
|
April 24, 2020
Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials
Sean M Murphy, Philip J Jeng, Sabrina A Poole, et al.
The Journal of Stone Disease
|
March 9, 1992
Gallstone lithotripsy (GSL): results of the Technomed Sonolith 3000 multicenter trials
J R Adwers, S Gordon, C Abernathy, et al.
Drug and Alcohol Dependence
|
December 7, 2018
Incidence of future arrests in adults involved in the criminal justice system with opioid use disorder receiving extended release naltrexone compared to treatment as usual
William E Soares, Donna Wilson, Michael S Gordon, et al.
Investigational New Drugs
|
May 13, 2009
A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumors
Anne M Traynor, Michael S Gordon, Dona Alberti, et al.
Applied Psychology. Health and Well-Being
|
October 15, 2013
A brief self-affirmation study to improve the experience of minority patients
Diana J Burgess, Brent C Taylor, Sean Phelan, et al.
Archives of Dermatological Research
|
December 19, 2016
N-Acetylglutaminoyl-S-farnesyl-L-cysteine (SIG-1191): an anti-inflammatory molecule that increases the expression of the aquaglyceroporin, aquaporin-3, in human keratinocytes
José R Fernández, Corey Webb, Karl Rouzard, et al.
Page
of 210